Mediolanum International Funds Ltd Sells 750 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mediolanum International Funds Ltd cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,827 shares of the medical equipment provider’s stock after selling 750 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Intuitive Surgical were worth $20,009,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Brookstone Capital Management grew its holdings in Intuitive Surgical by 17.2% in the 1st quarter. Brookstone Capital Management now owns 10,241 shares of the medical equipment provider’s stock valued at $4,087,000 after buying an additional 1,505 shares in the last quarter. Thrive Wealth Management LLC lifted its position in shares of Intuitive Surgical by 19.6% during the 1st quarter. Thrive Wealth Management LLC now owns 897 shares of the medical equipment provider’s stock valued at $358,000 after acquiring an additional 147 shares during the period. Fifth Third Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 44.8% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 1,199 shares of the medical equipment provider’s stock valued at $479,000 after acquiring an additional 371 shares during the period. Register Financial Advisors LLC bought a new stake in shares of Intuitive Surgical during the 1st quarter valued at $97,000. Finally, KRS Capital Management LLC lifted its position in shares of Intuitive Surgical by 19.8% during the 1st quarter. KRS Capital Management LLC now owns 1,240 shares of the medical equipment provider’s stock worth $495,000 after buying an additional 205 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Barclays upped their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Truist Financial upped their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Trading Up 0.9 %

NASDAQ ISRG traded up $4.48 during trading hours on Friday, hitting $516.11. 289,750 shares of the company’s stock were exchanged, compared to its average volume of 1,465,801. The stock has a 50-day simple moving average of $486.71 and a 200 day simple moving average of $440.96. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34. The firm has a market cap of $183.06 billion, a price-to-earnings ratio of 92.35, a PEG ratio of 5.40 and a beta of 1.39.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 52,192 shares of company stock valued at $25,398,571 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.